Compounds > 3-(4-5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2h-tetrazolium

3-(4-5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2h-tetrazolium and taxane

3-(4-5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2h-tetrazolium has been researched along with taxane* in 1 studies

Other Studies

1 other study(ies) available for 3-(4-5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2h-tetrazolium and taxane

ArticleYear
Overcoming EZH2 Inhibitor Resistance by Taxane in PTEN-Mutated Cancer.
    Theranostics, 2019, Volume: 9, Issue:17

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Cell Line, Tumor; Drug Resistance, Neoplasm; Enhancer of Zeste Homolog 2 Protein; Forkhead Box Protein O1; Humans; Male; Mice; Mice, Nude; Mice, SCID; Mutation; Promoter Regions, Genetic; Prostatic Neoplasms; Protein Binding; PTEN Phosphohydrolase; Taxoids; Tetrazolium Salts; Thiazoles

2019